Body Mass Index (BMI) and Infectious/Febrile Episodes in Children with Intermediate Risk Acute Lymphoblastic Leukemia (IR ALL)

References

• Ward E, DeSantis C, Robbins A, Kohler B, and Jemal A: Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64(2), 83–103, 2014.
   PubMed Web of Science ®Google Scholar
• Hunger SP, Winick NJ, Sather HN, and Carroll WL: Therapy of low-risk subsets of childhood acute lymphoblastic leukemia: when do we say enough? Pediatr Blood Cancer 45, 876–880, 2005.
   PubMed Web of Science ®Google Scholar
• Pui C-H, Yang JJ, Hunger SP, Pieters R, Schrappe M, et al.: Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol 33(27), 2938–2948, 2015.
   PubMed Web of Science ®Google Scholar
• O’Connor D, Bate J, Wade R, Clack R, Dhir S, et al.: Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003. Blood 124(7), 1056–1061, 2014.
   PubMed Web of Science ®Google Scholar
• Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon SP, et al.: Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol 30(14), 1663–1669, 2012.
   PubMed Web of Science ®Google Scholar
• Veerman AJ, Kamps WA, van den Berg H, van der Berg E, Bökkerink JP, et al.: Dutch Childhood Oncology Group: Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004). Lancet Oncol 10(10), 957–966, 2009.
   PubMed Web of Science ®Google Scholar
• Christensen MS, Heyman M, Möttönen M, Zeller B, Jonmundsson G, et al.: Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992–2001. Br J Haematol 131(1), 50–58, 2005.
   PubMed Web of Science ®Google Scholar
• Buitenkamp TD, Izraeli S, Zimmermann M, Forestier E, Heerema NA, et al.: Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. Blood 123(1), 70–77, 2014.
   PubMed Web of Science ®Google Scholar
• Graubner UB, Porzig S, Jorch N, Kolb R, Wessalowski R, et al.: Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 50(2), 259–263, 2008.
   PubMed Web of Science ®Google Scholar
• Rungoe C, Malchau EL, Larsen LN, and Schroeder H: Infections during induction therapy for children with acute lymphoblastic leukemia. The role of sulfamethoxazole–trimethoprim (SMX–TMP) prophylaxis. Pediatr Blood Cancer 55(2), 304–308, 2010.
   PubMed Web of Science ®Google Scholar
• Lücking V and Rosthøj S: Prediction of bacteremia in children with febrile episodes during chemotherapy for acute lymphoblastic leukemia. Pediatr Hematol Oncol 30(2), 131–140, 2013.
   PubMed Web of Science ®Google Scholar
• Li SD, Chen YB, Li ZG, Wu RH, Qin MQ, et al.: Infections during induction therapy of protocol CCLG-2008 in childhood acute lymphoblastic leukemia: a single-center experience with 256 cases in China. Chin Med J 128(4), 472–476, 2015.
   PubMed Web of Science ®Google Scholar
• Afzal S, Ethier MC, Dupuis LL, Tang L, Punnett AS, et al.: Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia. Pediatr Infect Dis J 28(12), 1064–1068, 2009.
   PubMed Web of Science ®Google Scholar
• Izraeli S, Vora A, Zwaan CM, and Whitlock J: How I treat ALL in Down's syndrome: pathobiology and management. Blood 123(1), 35–40, 2014.
   PubMed Web of Science ®Google Scholar
• Rackoff WR, Ge J, Sather HN, Cooper HA, Hutchinson RJ, et al.: Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol 21(4), 260–267, 1999.
   PubMed Web of Science ®Google Scholar
• McNeer JL and Nachman JB: The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers. Br J Haematol 149(5), 638–652, 2010.
   PubMed Web of Science ®Google Scholar
• Tomkins A and Watson F: Malnutrition and infection—a review. Nutrition policy discussion paper no. 5, UNSSCN, 1989. Available at: https://www.unscn.org/web/archives_resources/files/Policy_paper_No_5.pdf.
   Google Scholar
• Katona P and Katona-Apte J: The interaction between nutrition and infection. Clin Infect Dis 46(10), 1582–1588, 2008.
   PubMed Web of Science ®Google Scholar
• Belkaid Y and Hand T: Role of the microbiota in immunity and inflammation. Cell 157(1), 121–141, 2014.
   PubMed Web of Science ®Google Scholar
• Ramakrishna BS: The normal bacterial flora of the human intestine and its regulation. J Clin Gastroenterol 41, S2–S6, 2007.
   Web of Science ®Google Scholar
• Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, et al.: Role of the normal gut microbiota. World J Gastroenterol 21(29), 8787–8803, 2015.
   PubMed Web of Science ®Google Scholar
• Geva-Zatorsky N, Sefik E, Kua L, Pasman L, Tan TG, et al.: Mining the human gut microbiota for immunomodulatory organisms. Cell 168(5), 928–943, 2017.
   PubMed Web of Science ®Google Scholar
• Taur Y and Pamer EG: The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr Opin Infect Dis 26(4), 332–337, 2013.
   PubMed Web of Science ®Google Scholar
• Montassier E, Al-Ghalith GA, Ward T, Corvec S, Gastinne T, et al.: Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection. Genome Med 8(1), 49, 2016.
   PubMedGoogle Scholar
• Hingorani P, Seidel K, Krailo M, Mascarenhas L, Meyers P, et al.: Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: a report from the children’s oncology group. Pediatr Blood Cancer 57(6), 939–942, 2011.
   PubMed Web of Science ®Google Scholar
• Oğuz A, Karadeniz C, Pelit M, and Hasanoğlu A: Arm anthropometry in evaluation of malnutrition in children with cancer. Pediatr Hematol Oncol 16(1), 35–41, 1999.
   PubMed Web of Science ®Google Scholar
• Mei Z, Grummer-Strawn LM, Pietrobelli A, Goulding A, Goran MI, et al.: Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents. Am J Clin Nutr 75(6), 978–985, 2002.
   PubMed Web of Science ®Google Scholar
• Field AE, Laird N, Steinberg E, Fallon E, Semega-Janneh M, et al.: Which metric of relative weight best captures body fatness in children? Obes Res 11(11), 1345–1352, 2003.
   PubMedGoogle Scholar
• Daniels SR, Jacobson MS, McCrindle BW, Eckel RH, and Sanner BM: American heart association childhood obesity research summit report. Circulation 119(15), e489–517, 2009.
   PubMed Web of Science ®Google Scholar
• Freedman DS, Mei Z, Srinivasan SR, Berenson GS, and Dietz WH: Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr 150(1), 12–17.e2, 2007.
   PubMed Web of Science ®Google Scholar
• Demerath EW, Schubert CM, Maynard LM, Sun SS, Chumlea WC, et al.: Do changes in body mass index percentile reflect changes in body composition in children? Data from the Fels Longitudinal Study. Pediatrics 117(3), e487–495, 2006.
   PubMed Web of Science ®Google Scholar
• Martin-Calvo N, Moreno-Galarraga L, and Martinez-Gonzalez MA: Association between body mass index, waist-to-height ratio and adiposity in children: a systematic review and meta-Analysis. Nutrients 8(8), E512, 2016.
   PubMed Web of Science ®Google Scholar
• Rogers PC, Melnick SJ, Ladas EJ, Halton J, Baillargeon J, et al.: Children’s Oncology Group (COG) Nutrition Committee. Pediatr Blood Cancer 50(2 Suppl), 447–450, 2008.
   PubMed Web of Science ®Google Scholar
• ALL IC-BFM 2009 – TRIAL STEERING COMMITTEE. A Randomized Trial of the I-BFM-SG for the Management of Childhood non-B Acute Lymphoblastic Leukemia Final Version of Therapy Protocol from 14.08.2009. http://studyres.com/doc/8006251/all-ic-bfm-2009?page =30
   Google Scholar
• Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, et al.: Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol 27(5), v111–v118, 2016.
   PubMedGoogle Scholar
• Braden CD. Medscape. Neutropenia. http://emedicine.medscape.com/article/204821-overview#showall. Updated Feb 26, 2016.
   Google Scholar
• Centers for Disease Control and Prevention, National Center for Health Statistics. Clinical Growth Charts. https://www.cdc.gov/growthcharts/clinical_charts.htm. Updated June 16, 2017.
   Google Scholar
• Sung L, Lange BJ, Gerbing RB, Alonzo TA, and Feusner J: Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood 110, 3532–3539, 2007.
   PubMed Web of Science ®Google Scholar
• Bauer J, Jürgens H, and Frühwald MC: Important aspects of nutrition in children with cancer. Adv Nutr 2(2), 67–77, 2011.
   PubMed Web of Science ®Google Scholar
• Mason J and Nitenberg G: Cancer and nutrition: prevention and treatment, nestle nutrition workshop deries clinical and performance program. Basel 4, 275–284, 2000.
   Google Scholar
• Brinksma A: Nutritional status in children with cancer: prevalence, related factors, and consequences of malnutrition. Doctoral Thesis. University of Groningen, 2014.
   Google Scholar
• Taj MM, Pearson AD, Mumford DB, and Price L: Effect of nutritional status on the incidence of infection in childhood cancer. Pediatr Hematol Oncol 10(3), 283–287, 1993.
   PubMed Web of Science ®Google Scholar
• Viana Taveira MR, Lima LS, de Araújo CC, and de Mello MJ: Risk factors for central line–associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: a cohort study. Pediatr Blood Cancer 64(2), 336–342, 2017.
   PubMed Web of Science ®Google Scholar
• Georgiadou SP, Pongas G, Fitzgerald NE, Lewis RE, Rytting M, et al.: Invasive mold infections in pediatric cancer patients reflect heterogeneity in etiology, presentation, and outcome: a 10-year, single-institution, retrospective study. J Pediatr Infect Dis Soc 1(2), 125–135, 2012.
   PubMedGoogle Scholar
• Hughes WT, Price RA, Sisko F, Havron WS, Kafatos AG, et al.: Protein-calorie malnutrition: a host determinant for Pneumocystis carnii infection. Am J Dis Child 128(1), 44–52, 1974.
   PubMedGoogle Scholar
• Co-Reyes E, Li R, Huh W, and Chandra J: Malnutrition and obesity in pediatric oncology patients: causes, consequences, and interventions. Pediatr Blood Cancer 59(7), 1160–1167, 2012.
   PubMed Web of Science ®Google Scholar
• Burke ME, Lyden ER, Meza JL, Ladas EJ, Dasgupta R, et al.: Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the children’s oncology Group Soft Tissue Sarcoma Committee. Pediatr Blood Cancer 60(5), 748–753, 2013.
   PubMed Web of Science ®Google Scholar
• Asturias EJ, Corral JE, and Quezada J: Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia. Curr Oncol 17(2), 59–63, 2010.
   PubMed Web of Science ®Google Scholar
• Schenker S: Undernutrition in the UK. Brit Nutr Foundation Nutr Bull 28, 87–120, 2003.
   Google Scholar
• Lidia M, Maria PA, Ioana CM, Man A, Oana M, et al.: Evaluation of anthropometric and biochemical status in children with nutritional deficiency. Acta Medica Marisiensis 59(6), 293–297, 2013.
   Google Scholar
• Shah P, Jhaveri U, Idhate TB, Dhingra S, Arolkar P, et al.: Nutritional status at presentation, comparison of assessment tools, and importance of arm anthropometry in children with cancer in India. Indian J Cancer 52(2), 210–215, 2015.
   PubMed Web of Science ®Google Scholar
• Mosby TT, Barr RD, and Pencharz PB: Nutritional assessment of children with cancer. J Pediatr Oncol Nurs 26(4), 186–197, 2009.
   PubMed Web of Science ®Google Scholar
• White M, Davies P, and Murphy A: Validation of percent body fat indicators in pediatric oncology nutrition assessment. J Pediatr Hematol Oncol 30(2), 124–129, 2008.
   PubMed Web of Science ®Google Scholar
• PredniSONE, Information: http://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Roxane/Prednisone%20Reformulated/PredniSONEReform.pdf, 2012. accessed: 20.08.2017.
   Google Scholar
• Reilly JJ, Brougham M, Montgomery C, Richardson F, Kelly A, et al.: Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab 86(8), 3742–3745, 2001.
   PubMed Web of Science ®Google Scholar